Skip to main content

Advertisement

SpringerLink
Log in

Pamidronate treatment in rheumatology practice: a comprehensive review

  • Review Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Pamidronate, along with other bisphosphonates, has been used for treatment of bone pain secondary to malignant involvement or metastatic disease for years. Some data, however, have also accumulated on the utility of pamidronate in a variety of benign conditions frequently handled by rheumatologists. This study aims to review the available published data regarding the potential use of pamidronate in rheumatology practice. Methods include the review of relevant articles retrieved by a PUBMED search utilizing the index term “pamidronate”. All available randomized control trials, open trials, and case series, as well as properly reported case studies evaluating usage of pamidronate in rheumatic disorders, have been included in the literature review. The efficacy of pamidronate in patients with spondyloarthropathies; synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome; hypertrophic osteoarthropathy; osteoporotic vertebral fractures; chronic back pain due to disk disease or spinal stenosis; Charcot arthropathy; transient osteoporosis; and complex regional pain syndrome-I, has been demonstrated in more than 40 reports, the majority of which, however, were not controlled studies. In some of reviewed conditions, aside from providing analgesic relief, pamidronate may also have disease-modifying properties. While used in different doses in a variety of rheumatic disorders, pamidronate was generally reported to be well tolerated with an overall good safety profile. Pamidronate may represent an effective and safe choice for a spectrum of rheumatic patients, suffering from intractable musculoskeletal pain, unresponsive to traditionally recommended therapies. Large randomized, controlled studies examining the efficacy of pamidronate in the rheumatic conditions are urgently needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A et al (2002) A six-months randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal anti-inflammatory drug-refractory ankylosing spondylitis. Arthritis Rheum 46:766–773

    Article  CAS  PubMed  Google Scholar 

  2. Maksymowych WP, Jhangri GS, LeClercq S, Skeith K, Yan A, Russell AS (1998) An open study of pamidronate in the treatment of refractory ankylosing spondylitis. J Rheumatol 25:714–717

    CAS  PubMed  Google Scholar 

  3. Maksymowych WP, Lambert R, Jhangri GS, LeClercq S, Chiu P, Wong B et al (2001) Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J Rheumatol 28:144–155

    CAS  PubMed  Google Scholar 

  4. Haibel H, Brandt J, Rudwaleit M, Soerensen H, Sieper J, Braun J (2003) Treatment of active ankylosing spondylitis with pamidronate. Rheumatology 42:1018–1020

    Article  CAS  PubMed  Google Scholar 

  5. Cairns AP, Wright SA, Taggart AJ, Coward SM, Wright GD (2005) An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover. Ann Rheum Dis 64:338–339

    Article  CAS  PubMed  Google Scholar 

  6. Grover R, Shankar S, Aneja R, Marwaha V, Gupta R, Kumar A (2006) Treatment of ankylosing spondylitis with pamidronate: an open label study. Ann Rheum Dis 65:688–689

    Article  CAS  PubMed  Google Scholar 

  7. Toussirot E, Le Huede G, Lohse A, Cedos J-P, Wendling D (2006) Transient efficacy of pulse pamidronate treatment in active spondyloarthropathies: an open study of 35 cases. Clin Exp Rheumatol 24:348

    CAS  PubMed  Google Scholar 

  8. Maksymowych WP, Aaron S, Russell AS (2001) Treatment of refractory symphysitis pubis with intravenous pamidronate. J Rheumatol 28:2754–2757

    CAS  PubMed  Google Scholar 

  9. Marshall H, Bromilow J, Thomas AL, Arden NK (2002) Pamidronate: a novel treatment for the SAPHO syndrome? Rheumatology 41:231–233

    Article  CAS  PubMed  Google Scholar 

  10. Courtney PA, Hosking DJ, Fairbairn KJ, Deighton CM (2002) Treatment of SAPHO with pamidronate. Rheumatology 41:1196–1198

    Article  CAS  PubMed  Google Scholar 

  11. Guignard S, Job-Deslandre C, Sayag-Boukris V, Kahan A (2002) Pamidronate treatment in SAPHO syndrome. Joint Bone Spine 69:392–396

    Article  CAS  PubMed  Google Scholar 

  12. Amital H, Applbaum YH, Aamar S, Daniel N, Rubinow A (2004) SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology 43:658–661

    Article  CAS  PubMed  Google Scholar 

  13. Valls-Roc M, Sanmarti M, Salles M, Holgado S, Olive A (2005) SAPHO syndrome and pamidronate revisited. Rheumatology 44:137

    Article  CAS  PubMed  Google Scholar 

  14. Tehrani R (2005) SAPHO syndrome treated with pamidronate. Indian J Dermatol Venereol Leprol 71:273–275

    Article  PubMed  Google Scholar 

  15. Solau-Gervais E, Soubrier M, Gerot I, Grange L, Puechal X, Sordet C et al (2006) The usefulness of bone remodeling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome. Rheumatology 45:339–342

    Article  CAS  PubMed  Google Scholar 

  16. Kerrison C, Davidson JE, Cleary AG, Beresford MW (2004) Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology 34:1246–1251

    Article  Google Scholar 

  17. Simm PJ, Allen RC, Zacharin MR (2008) Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis. J Pediatr 152:571–575

    Article  CAS  PubMed  Google Scholar 

  18. Gleeson H, Wiltshire E, Briody J, Hall J, Chaitow J, Sillence D et al (2008) Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape. J Rheumatol 35:707–712

    PubMed  Google Scholar 

  19. Guyot-Drouot M-H, Solau-Gervais E, Cortet B, Deprez X, Chastanet P, Cotten A et al (2000) Rheumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonates. J Rheumatol 27:2418–2423

    CAS  PubMed  Google Scholar 

  20. Bhansali A, Singh R, Sriraam M, Bhadada S (2006) Pachydermoperiostitis and bisphosphonates. J Assoc Physicians India 54:340

    CAS  PubMed  Google Scholar 

  21. Garske LA, Bell SC (2002) Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis. Chest 121:1363–1364

    Article  PubMed  Google Scholar 

  22. Amital H, Applbaum YH, Vasiliev L, Rubinow A (2004) Hypertrophic pulmonary osteoarthropathy: control of pain and symptoms with pamidronate. Clin Rheumatol 23:330–332

    Article  PubMed  Google Scholar 

  23. Speden D, Nicklason F, Francis H, Ward J (1997) The use of pamidronate in hypertrophic pulmonary osteoarthropathy. Aust N Z Med 27:307–310

    CAS  Google Scholar 

  24. Suzuma T, Sakurai T, Yoshimura G, Umemura T, Tamaki T, Yoshimasu T et al (2001) Pamidronate-induced remission of pain associated with hypertrophic pulmonary osteoarthropathy in chemoendocrine therapy-refractory inoperable metastatic breast carcinoma. Anticancer Drugs 12:731–734

    Article  CAS  PubMed  Google Scholar 

  25. Abdulla AJ (2000) Use of pamidronate for acute pain relief following osteoporotic vertebral fractures. Rheumatology 39:567–568

    Article  CAS  PubMed  Google Scholar 

  26. Gangji V, Appelboom T (1999) Analgesic effect of intravenous pamidronate on chronic back pain due to osteoporotic vertebral fractures. Clin Rheum 18:266–267

    Article  CAS  Google Scholar 

  27. Armingeat T, Brondino R, Pham T, Legre V, Lafforgue P (2006) Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study. Osteoporos Int 17:1659–1665

    Article  CAS  PubMed  Google Scholar 

  28. Laroche M, Cantogrel S, Jamard B, Constantin A, Zabranieski L, Cantagrel A et al (2006) Comparison of the analgesic efficacy of pamidronate and synthetic human calcitonin in osteoporotic vertebral fractures: a double-blind controlled study. Clin Rheumatol 25:683–686

    Article  CAS  PubMed  Google Scholar 

  29. Poujol D, Ristori JM, Dubost JJ, Soubrier M (2007) Efficacy of pamidronate in erosive degenerative disk disease: a pilot study. Joint Bone Spine 74:663–664

    Article  PubMed  Google Scholar 

  30. Feld J, Rosner I, Avshovich N, Boulman N, Slobodin G, Rozenbaum M (2009) An open study of pamidronate in the treatment of refractory degenerative lumbar spinal stenosis. Clin Rheum 28(6):715–717

    Article  Google Scholar 

  31. Pappagallo M, Breuer B, Schneider A, Sperber K (2003) Treatment of chronic mechanical spinal pain with intravenous pamidronate: a review of medical records. J Pain Symptom Manage 26:678–683

    Article  CAS  PubMed  Google Scholar 

  32. Selby PL, Young MJ, Boulton AJ (1994) Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med 11:28–31

    Article  CAS  PubMed  Google Scholar 

  33. Naqvi A, Cuchacovich R, Saketkoo L, Espinosa LR (2008) Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up. Am J Med Sci 335:145–148

    Article  PubMed  Google Scholar 

  34. Anderson JJ, Woelffer KE, Holtzman JJ, Jacobs AM (2004) Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surgery 43:285–289

    Article  Google Scholar 

  35. Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR et al (2001) Bisphosphonates in the treatment og Charcot neuroarthropathy: a double-blind randomized control trial. Diabetologia 44:2032–2037

    Article  CAS  PubMed  Google Scholar 

  36. Devogelaer JP, Dall'Armellina S, Huaux JP, Nagant de Deuxchaines C (1988) Dramatic improvement of intractable reflex sympathetic dystrophy syndrome by intravenous infusions of the second generation bisphosphonate APD [abstract]. J Bone Min Res 3(Suppl):S122

    Google Scholar 

  37. Brown SC, Jeavons M, Stinson J (2005) Effectiveness of pamidronate for treating intractable chronic neuropathic pain. Case report of two adolescents. Clin J Pain 21:549–552

    Article  PubMed  Google Scholar 

  38. Maillefert JF, Chatard C, Owen S, Peere T, Tavernier C, Tebib J (1995) Treatment of refractory reflex sympathetic dystrophy with pamidronate. Ann Rheum Dis 54:687

    Article  CAS  PubMed  Google Scholar 

  39. Cortet B, Flipo R-M, Coquerelle P, Duquesnoy B, Delcambre B (1997) Treatment of severe, recalcitrant reflex sympathetic dystrophy: assessment of efficacy and safety of the second generation bisphosphonate pamidronate. Clin Rheum 16:51–56

    Article  CAS  Google Scholar 

  40. Maillefert JF, Cortet B, Aho S (1999) Pooled results from 2 trials evaluating bisphosphonates in reflex sympathetic dystrophy. J Rheumatol 26:8

    Google Scholar 

  41. Kubalek I, Fain O, Paries J, Kettaneh A, Thomas M (2001) Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases. Rheumatology 40:1394–1397

    Article  CAS  PubMed  Google Scholar 

  42. Robinson JN, Sandom J, Chapman PT (2004) Efficacy of pamidronate in complex regional pain syndrome type I. Pain Med 5:276–280

    Article  PubMed  Google Scholar 

  43. Varenna M, Zucchi F, Binelli L, Failoni S, Gallazzi M, Sinigaglia L (2002) Intravenous pamidronate in the treatment of transient osteoporosis of the hip. Bone 31:96–101

    Article  CAS  PubMed  Google Scholar 

  44. Petcu EB, Schug SA, Smith RH (2002) Clinical evaluation of onset of analgesia using intravenous pamidronate in metastatic bone pain. J Pain Symptom Manage 24:281–282

    Article  PubMed  Google Scholar 

  45. Fulfaro F, Cassucio A, Ticozzi C, Ripamonti C (1998) The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials. Pain 78:157–169

    Article  CAS  PubMed  Google Scholar 

  46. Bonabello A, Galmozzi MR, Bruzzese T, Zara GP (2001) Analgesic effect of biphosphonates in mice. Pain 91:269–275

    Article  CAS  PubMed  Google Scholar 

  47. Bonabello A, Galmozzi MR, Canaparo R, Serpe L, Zara GP (2003) Long-term analgesic effect of clodronate in rodents. Bone 33:567–574

    Article  CAS  PubMed  Google Scholar 

  48. Ceccini MG, Fleisch H (1990) Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouth mononuclear phagocyte lineage. J Bone Miner Res 5:1019–1027

    Article  Google Scholar 

  49. Pennanen N, Lapinjoki S, Urtti S, Monkkonen J (1995) Effect of liposomal and free biphosphonates on the IL-1β, IL-6 and TNFα secretion from RAW 264 cells in vitro. Pharmacol Res 12:916–922

    Article  CAS  Google Scholar 

  50. Thiebaud D, Sauty A, Burckhardt P, Leuenberger P, Sitzler L, Green JR et al (1997) An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int 61:386–392

    Article  CAS  PubMed  Google Scholar 

  51. Van Offel JF, Schuerwegh AJ, Bridts CH, Bracke PG, Stevens WJ, De Clerck LS (2001) Influence of cyclic intravenous pamidronate on proinflammatory monocytic cytokine profiles and bone density in rheumatoid arthritis treated with low dose prednisolone and methotrexate. Clin Exp Rheumatol 19:13–20

    PubMed  Google Scholar 

  52. Carbone LD, Warrington KJ, Barrow KD, Pugazhenthi M, Watsky MA, Somes G et al (2006) Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles. Clin Exp Immunol 146:371–380

    Article  CAS  PubMed  Google Scholar 

  53. Kunzmann V, Bauer E, Wilhelm M (1999) Gamma/delta T-cell stimulation by pamidronate. N Engl J Med 340:737–738

    Article  CAS  PubMed  Google Scholar 

  54. Kunzmann V, Bauer E, Feurle J, Weiissinger F, Tony HP, Wilhelm M (2000) Stimulation of gamma delta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 96:384–392

    CAS  PubMed  Google Scholar 

  55. Conti L, Casetti R, Cardone M, Varano B, Martino A, Belardelli F, Poccia F, Gessani S (2005) Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. J Immunol 174:252–260

    CAS  PubMed  Google Scholar 

  56. Djokanovic N, Klieger-Grossmann C, Koren G (2008) Does treatment with bisphosphonates endanger the human pregnancy? J Obstet Gynaecol Can 30:1146–1148

    PubMed  Google Scholar 

Download references

Disclosures

None

Author information

Authors and Affiliations

  1. Department of Internal Medicine A, Bnai Zion Medical Center and Ruth & Bruce Rappaport Faculty of Medicine, Technion, 47, Golomb St, Haifa, 31048, Israel

    Gleb Slobodin & Majed Odeh

  2. Department of Rheumatology, Bnai Zion Medical Center and Ruth & Bruce Rappaport Faculty of Medicine, Technion, 47, Golomb St, Haifa, 31048, Israel

    Itzhak Rosner, Joy Feld, Doron Rimar, Michael Rozenbaum & Nina Boulman

Authors
  1. Gleb Slobodin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Itzhak Rosner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joy Feld
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Doron Rimar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael Rozenbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nina Boulman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Majed Odeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gleb Slobodin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Slobodin, G., Rosner, I., Feld, J. et al. Pamidronate treatment in rheumatology practice: a comprehensive review. Clin Rheumatol 28, 1359–1364 (2009). https://doi.org/10.1007/s10067-009-1256-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-009-1256-2

Keywords

Search

Navigation